The landscape of dementia diagnosis has evolved considerably with the arrival of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-based mostly exams that may detect Alzheimer's pathology many years before indications emerge. While these technological advancements signify remarkable progress in understanding neurodegenerative disorders, they've not diminis... https://roberti420mzj2.idblogmaker.com/profile